Table 2 One-year clinical outcomes after TAVR of the entire study population as well as of patients with and without CAD separately
|  | Overall population (n = 553) | CAD (n = 333) | No CAD (n = 220) | P value |
|---|---|---|---|---|
SYNTAX score residual | 4.3 ± 6.7 | 7.2 ± 7.3 | 0.0 |  < 0.01 |
One-year mortality | 76 (13.7) | 41 (12.3) | 35 (15.9) | 0.23 |
30-day mortality | 16 (2.9) | 11 (3.3) | 5 (2.3) | 0.47 |
MACCE | 115 (20.8) | 74 (22.2) | 41 (18.6) | 0.31 |
Myocardial infarction | 7 (1.3) | 7 (2.1) | 0 (0.0) |  < 0.01 |
TLR | 11 (2.0) | 11 (3.3) | 0 (0.0) |  < 0.01 |
Stroke | 9 (1.6) | 6 (1.8) | 3 (1.4) | 0.69 |
Cardiac decompensation | 12 (2.2) | 9 (2.7) | 3 (1.4) | 0.28 |